Evidence map›Paper›PMID 41561092›Full record

ArticleFrontiers in cellular and infection microbiology2025

Immune activation and mucin dysregulation in pediatric refractory

Fen Liu, Qinglin Wang, Qi Cheng, Han Zhang

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Early clinical predictors of macrolide-resistant Mycoplasma pneumoniae pneumonia in hospitalized children during the 2024 outbreak in South Korea.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Early prediction of plastic bronchitis in pediatric patients withFrontiers in cellular and infection microbiology · 2026
    Article
  6. Immune dysregulation inFrontiers in immunology · 2026
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fen Liu *Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Qinglin Wang *Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Qi ChengDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Han ZhangDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Children with refractory Methods: From January 2022 to December 2023, children meeting the criteria for RMPP and requiring bronchoscopy were enrolled, and BALF samples were collected for analysis. Patients were stratified according to the presence or absence of mucus plugs. Clinical features, serologic parameters, BALF cytokine profiles, macrolide-resistance mutations, and epithelial and mucin biomarkers were compared between groups. Correlations between systemic inflammatory markers and BALF markers were analyzed, followed by enrichment analyses of differentially expressed BALF markers. Finally, factors independently associated with mucus plug formation were identified. Results: Eighty-eight children with RMPP were enrolled, including 37 with mucus plugs and 51 without. The mucus plug group required more frequent bronchoscopy and exhibited lower lymphocyte, monocyte, platelet, total protein, albumin, sodium, and potassium levels. Conversely, C-reactive protein (CRP), procalcitonin (PCT), creatine kinase (CK), lactate dehydrogenase (LDH), and serum ferritin levels were markedly elevated. BALF analysis revealed significantly higher levels of interleukin (IL)-2, IL-4, IL-6, IL-12p70, IL-17, interferon-γ (IFN-γ), tumor necrosis factor-α (TNF-α), Krebs von den Lungen-6 (KL-6), surfactant protein A (SP-A), and MUC5B in the mucus plug group. Rates of macrolide-resistance mutations were comparable between groups. Serum LDH, CRP, and CK levels correlated positively with BALF pro-inflammatory cytokines (IL-6, IFN-γ, and TNF-α), whereas albumin and sodium levels showed inverse correlations with these cytokines and with epithelial injury markers (KL-6 and SP-A). Enrichment analyses indicated that differentially expressed cytokines and mucins were primarily involved in inflammation-related pathways and immune effector processes. In multivariable analysis, only serum total protein remained independently associated with mucus plug formation. Conclusions: Children with RMPP and mucus plugs exhibited higher BALF cytokine levels, elevated epithelial injury markers (KL-6 and SP-A), and relatively increased MUC5B expression. Lower serum total protein was independently associated with mucus plug formation. These findings refine the pathophysiological understanding of RMPP with mucus plugs and may inform targeted anti-inflammatory and mucus-modulating therapeutic strategies.

Indexed as

MucinsMucusMycoplasma pneumoniaePneumonia, MycoplasmaAnti-Bacterial AgentsBiomarkersBronchoalveolar Lavage FluidChildChild, PreschoolCytokinesDrug Resistance, BacterialFemaleHumansMacrolidesMaleAnti-Bacterial AgentsBiomarkersCytokinesMacrolidesMucinsBALFepithelial injuryMUC5Bmucinsmucus plug

Identifiers

PMID41561092
PMCPMC12812597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.